Studies show that intramuscular B12 administration achieves superior serum cobalamin levels compared to oral routes, particularly in patients with absorption challenges
availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial
But it also has a thousand other effects, tissue growth, insulin resistance, raising IGF-1 and the risk of acromegaly
It may also improve joint flexibility and mobility, making it a great option for aging individuals and active professionals
The encapsulated format must not be interpreted as a human dose or route of administration
Patients receiving B12 injections should inform their healthcare provider of all medications, as certain drugs (including metformin, proton pump inhibitors, and chloramphenicol) can affect B12 absorption or metabolism
